Photo of Pat Fallon
R United States House · District 4 · Texas On the 2026 ballot

Rep. Pat Fallon

Compare
Total votes
2,837
all sessions
Attendance
98%
65 missed
Near the chamber average
With party
93%
of cast votes
Near the chamber average
Bipartisan score
4%
crosses aisle rarely
Near the chamber average
Sponsored
748
bills & resolutions
Lower than 78% of chamber peers
Committees
8
assignments
748 bills and resolutions

Sponsored bills

Total
748
Primary
60
Co-sponsor
688
This page
748
matching current filters
Co-sponsor HR 1262
Passed · Maryland House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HRES 912
In committee · Maryland House · Co-sponsor
Recognizing the 75th anniversary of the Battle of the Chosin Reservoir during the Korean conflict.

Maddy summaryHRES 912 is a ceremonial resolution recognizing the 75th anniversary of the Battle of the Chosin Reservoir (November 27-December 13, 1950) during the Korean War. It commemorates the military campaign involving U.S. and UN forces, highlighting their resilience against Chinese forces amid extreme cold, the evacuation of over 105,000 troops, and the valor of units like the 1st Marine Division. The resolution urges the House to honor the sacrifices of service members who suffered over 10,500 battle casualties and 7,310 nonbattle casualties (primarily from frostbite). As a non-binding commemorative measure, it does not create new policies or affect any individuals or entities.

In committee Nov 25, 2025 1 co-sponsor
Co-sponsor HRES 782
Passed · Maryland House · Co-sponsor
Expressing condolences and support for the victims of the July 4 flooding in Texas, honoring acts of heroism, and committing to stand with those impacted by these floods.

Maddy summaryHRES 782 is a non-binding House resolution expressing condolences to victims of the July 4, 2025, catastrophic floods in Texas, which caused at least 135 deaths (including 37 children) and widespread destruction. It honors first responders who rescued over 850 people and community heroes like camp staff who saved children, while committing the House to stand with affected Texans. The resolution does not create new laws or allocate funds - it formally mourns the loss of life, recognizes acts of courage, and urges prioritization of rebuilding infrastructure and support for vulnerable residents. This symbolic gesture was introduced by multiple Texas representatives and referred to the Transportation Committee.

Passed Nov 17, 2025 1 co-sponsor
Co-sponsor HR 5948
In committee · Maryland House · Co-sponsor
To designate the facility of the United States Postal Service located at 500 Sergeant Gonzales Drive in Fort Davis, Texas, as the "Sergeant Manuel Sillas Gonzales Post Office".

Maddy summaryThis bill names a specific U.S. Postal Service facility in Fort Davis, Texas, as the "Sergeant Manuel Sillas Gonzales Post Office." It directly affects the postal facility located at 500 Sergeant Gonzales Drive by changing its official name. The bill requires all federal documents, maps, and records to reference the facility by its new name moving forward. This is a ceremonial naming bill with no policy changes or financial impact.

In committee Nov 7, 2025 1 co-sponsor
Co-sponsor HR 5908
In committee · Maryland House · Co-sponsor
Non-Essential Workers Transparency Act

Maddy summaryThis bill requires U.S. Executive agencies to report detailed workforce data when a government funding lapse (covered period) ends. Agencies must submit within 30 days a report showing the total number of employees before the lapse, salaries paid during the prior fiscal year, and specific counts/pay rates for both furloughed (non-essential) workers and others during the lapse. The reports, submitted to designated congressional committees, will be published online for public access. Additionally, the Congressional Budget Office must issue a public report on the economic impact of each funding lapse. The bill affects all Executive agencies (like federal departments) and mandates transparency about workforce impacts during government shutdowns.

In committee Nov 4, 2025 1 co-sponsor
Co-sponsor HR 5815
In committee · Maryland House · Co-sponsor
District of Columbia Medicaid Fairness Act

Maddy summaryHR 5815, the District of Columbia Medicaid Fairness Act, adjusts federal Medicaid funding for Washington D.C. by setting a specific Federal Medical Assistance Percentage (FMAP) for the district. It directly affects D.C. residents enrolled in Medicaid by guaranteeing a minimum federal funding share: 70% for fiscal years before 2027, gradually decreasing to 55% by 2029. For fiscal years 2030 and beyond, D.C. will receive the standard FMAP rate calculated under the Social Security Act, without the special adjustment. This change ensures D.C. receives a higher federal share than it would under the standard formula until 2029, after which it aligns with other states. The bill modifies Section 1905 of the Social Security Act to implement these funding adjustments.

In committee Oct 24, 2025 1 co-sponsor
Co-sponsor HR 5721
In committee · Maryland House · Co-sponsor
Protect Our Judiciary Act of 2025

Maddy summaryHR 5721, the Protect Our Judiciary Act of 2025, amends federal law to prohibit protests near judicial buildings. It makes it illegal to picket, parade, or use loud vehicles like sound trucks near buildings occupied by judges, jurors, witnesses, or court officers. Violators face fines or up to one year in prison. The bill directly affects individuals engaging in demonstrations near these locations, expanding existing restrictions to specifically include noise-making devices and other public demonstrations.

In committee Oct 8, 2025 1 co-sponsor
Co-sponsor HR 842
In committee · Maryland House · Co-sponsor
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Maddy summaryThis bill adds Medicare coverage for multi-cancer early detection screening tests (blood or biological tests analyzing cell-free DNA) starting January 1, 2028. It directly affects Medicare beneficiaries aged 68 and older (starting in 2028, with the age limit increasing by 1 year annually), requiring tests to be FDA-cleared and deemed reasonable/necessary by the Secretary for early cancer detection across multiple organ sites. Payment will initially match current stool DNA test rates before 2031, then shift to a lower rate or new payment system after 2031, with limits preventing more than one test per year. The bill explicitly states it does not alter coverage for existing cancer screenings like breast, colorectal, or prostate cancer tests.

In committee Oct 3, 2025 1 co-sponsor
Co-sponsor HR 38
In committee · Maryland House · Co-sponsor
Constitutional Concealed Carry Reciprocity Act of 2025

Maddy summaryThis bill would require all states to recognize valid concealed carry permits issued by other states, allowing permit holders to carry concealed handguns (excluding machine guns) in any state that either issues such permits or doesn't prohibit concealed carry. It directly affects law-abiding gun owners with valid permits from their home state, ensuring they can carry in states with similar permit systems or no prohibitions. Key provisions include treating valid permit documents as proof of legal carry (reducing officer stops), shifting the burden of proof to prosecutors if challenged, and allowing civil lawsuits for violations with attorney's fee awards. The bill does not override state laws restricting firearms on private property or government land, nor does it affect federal gun restrictions like those in section 922(q).

In committee Oct 3, 2025 1 co-sponsor
Primary HR 5179
In committee · Maryland House · Lead sponsor
District of Columbia Attorney General Appointment Reform Act of 2025

Maddy summaryThis bill changes how the District of Columbia's Attorney General is appointed. It requires the President to appoint the DC Attorney General directly (replacing the current mayoral appointment), with the position serving at the President's pleasure and ending when the President's term ends - no Senate confirmation needed. The current Attorney General's term ends immediately upon the bill's enactment. The change affects the DC Attorney General's office and DC residents, as the Attorney General handles local law enforcement and legal matters for the district.

In committee Sep 30, 2025 0 co-sponsors
Showing 61 to 70 of 748 bills
Previous 1 … 6 7 8 … 75 Next